During the past few decades, polymeric micelles have raised special attention as novel
nano-sized drug delivery systems for optimizing the treatment and diagnosis of numerous …

Though much progress has been made in drug delivery systems, the design of a suitable
carrier for the delivery of hydrophobic drugs is still a major challenge for researchers. The …

Poorly soluble drugs often encounter low bioavailability and erratic absorption patterns in
the clinical setting. Due to the rising number of compounds having solubility issues, finding …

Micelles are colloidal particles with a size around 5–100 nm which are currently under
investigation as carriers for hydrophobic drugs in anticancer therapy. Currently, five micellar …

As we enter the twenty-first century, research at the interface of polymer chemistry and the
biomedical sciences has given rise to the first nano-sized (5–100 nm) polymer-based …

Polymeric micelles (PM) system, as an efficient drug carrier, has received growing scientific
attention in recent years owing to its solubilization, selective targeting, P-glycoprotein …

Breast cancer is one of the most common types of cancer among women globally. It is
caused by mutations in the estrogen/progesterone receptors and conventional treatment …

Pluronic® block copolymers are found to be an efficient drug delivery system with multiple
effects. The incorporation of drugs into the core of the micelles formed by Pluronic® results …

Polymer nanomaterials have sparked a considerable interest as vehicles used for diagnostic
and therapeutic agents; research in nanomedicine has not only become a frontier movement …

One of the major causes of failure in cancer chemotherapy is multidrug resistance (MDR),
where cancer cells simultaneously become resistant to different anticancer drugs. Over …